Negative pressure wounds therapy (NPWT) device system is the most commonly used therapy to treat acute and chronic wounds. These systems promote wound healing, reduce the recurrent use of dressings (as in the case of dressing changes in traditional wound care dressings), provide efficient option for management of closed surgical incision lines, and improve patient well-being. They consist of a vacuum pump, drainage tubing, and a dressing set. The pump may be stationary or portable that relies on AC or battery power, allows for regulation of the suction strength, possesses alarms to indicate loss of suction, and has a replaceable collection canister. The dressing sets contain either foam or gauze dressing to be placed in the wound and an adhesive film drape to seal the wound. The drainage tubes are available in a variety of configurations, depending on the dressings used and the wound being treated.
NPWT devices market is poised to reach $2,746 million by 2022 from $2,082 million in 2015, growing at a CAGR of 4.0% from 2016 to 2022. The growth of NPWT devices market is supported by the rise in incidence of chronic diseases such as diabetes mellitus and obesity, increase in patient awareness regarding cost-effective NPWT devices such as single-use disposable devices, and casualties caused due to accidents and trauma. However, lack of evidence of clinical effectiveness and high cost of the NPWT devices in developing countries are expected to restrain the market growth.
The report segments the NPWT devices market on the basis of product type, application, end user, and geography. According to the product type, it is bifurcated into single-use NPWT devices and conventional NPWT devices market. On the basis of application, it is divided into chronic wounds and acute wounds. Considering the end-user segment, the market is segregated into hospitals & clinics, ambulatory surgery centers, and home care settings. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Over the past few years, the key players have adopted product development (including product launches, approvals, and clinical trials) as its key developmental strategy. For instance, in 2012, Smith & Nephew launched “PICO,” which is a single-use NPWT device. It is lightweight, disposable, and operates without a canister, and is therefore ideally suited for delivery of NPWT to outpatients, patients at home, and patients who do not want to have restricted mobility. Moreover, reimbursement policies for these devices have further increased the demand for such products. For instance, Medicare created two new HCPCS codes (G0456 & G0457) to provide a mechanism for payment of NPWT using a disposable device that is not durable medical equipment (DME).
Key Benefits: FOR STAKEHOLDERS:
This report offers an extensive analysis of the current and emerging market trends and dynamics in the world NPWT devices market.
Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities in these geographies.
This study evaluates competitive landscape to predict the competitive environment across the geographies.
A detailed quantitative analysis of the current market and estimations through 2014–2022, which assist to identify the prevailing opportunities, is explained.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
Region- and country-wise, NPWT devices market conditions are comprehensively analyzed.
KEY MARKET SEGMENTS:
By Product Type
Single-Use NPWT Devices
Conventional NPWT Devices
Diabetic Foot Ulcer
Venous Leg Ulcer
Burns & Trauma
By End User
Hospitals & Clinics
Ambulatory Surgery Centers (ASCs)
Home Care Settings
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Key Findings
3.3 Market Dynamics
18.104.22.168 Rapidly aging population and favorable demographics worldwide
22.214.171.124 Rise in incidence of chronic conditions
126.96.36.199 Technological advancements to deal with complex wounds
188.8.131.52 Lower-cost models to drive the NPWT devices market
184.108.40.206 Increased awareness to reduce healthcare costs
220.127.116.11 Unnoticed Complications of NPWT
18.104.22.168 Lack of evidence of Clinical effectiveness of NPWT
22.214.171.124 Need for experienced caregivers
126.96.36.199 Increased focus towards advanced treatment protocols
188.8.131.52 Significant unmet need in wound care
184.108.40.206 Opportunities in Emerging Markets
3.4 Reimbursement Scenario
3.4.1 Favourable reimbursement policies for PICO NPWT system to stimulate the market growth
3.5 Government Regulations
3.5.1 U.S. FDA
3.5.2 Europe CE Mark
3.5.3 Ministry of Health, Labour and Welfare (MHLW)
3.6 Clinical Trials
CHAPTER 4 WORLD NPWT DEVICES MARKET, BY PRODUCT
4.1.1 Components of NPWT system
4.1.2 Market size and forecast
4.2 Single-use disposable NPWT devices
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Conventional NPWT devices
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
CHAPTER 5 WORLD NPWT DEVICES MARKET, BY APPLICATION
5.1.1 Market size and forecast
5.2 Chronic wounds
5.2.1 Market size and forecast
5.2.2 Pressure ulcers
220.127.116.11 Market size and forecast
5.2.3 Diabetic foot ulcers
18.104.22.168 Market size and forecast
5.2.4 Venous leg ulcers
22.214.171.124 Market size and forecast
5.2.5 Arterial ulcers
126.96.36.199 Market size and forecast
5.3 Acute wounds
5.3.1 Market size and forecast
5.3.2 Burns & trauma
188.8.131.52 Market size and forecast
5.3.3 Surgical wounds
184.108.40.206 Market size and forecast
CHAPTER 6 WORLD NPWT DEVICES MARKET, BY END USER
6.1.1 Market size and forecast
6.2 Hospitals & clinics
6.2.1 Market size and forecast
6.3 Ambulatory surgery centers
6.3.1 Market size and forecast
6.4 Home care settings
6.4.1 Market size and forecast
CHAPTER 7 WORLD NPWT DEVICES MARKET, BY GEOGRAPHY
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.2.4 U.S. market size and forecast
7.2.5 Canada market size and forecast
7.2.6 Mexico market size and forecast
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.3.4 Germany market size and forecast
7.3.5 France market size and forecast
7.3.6 U.K. market size and forecast
7.3.7 Italy market size and forecast
7.3.8 Spain market size and forecast
7.3.9 Rest of Europe market size and forecast
7.4 Asia Pacific
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.4.4 Japan market size and forecast
7.4.5 China market size and forecast
7.4.6 India market size and forecast
7.4.7 Australia market size and forecast
7.4.8 South Korea market size and forecast
7.4.9 Rest of Asia-Pacific market size and forecast
7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
7.5.4 Brazil market size and forecast
7.5.5 UAE market size and forecast
7.5.6 Saudi Arabia market size and forecast
7.5.7 Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1 Devon Medical
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.2 Talley Group Limited
8.2.1 Company overview
8.2.2 Operating business segments
8.3 Paul Hartmann AG
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Business performance
8.4 Smith & Nephew plc
8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating business segments
8.4.4 Business performance
8.4.5 Key Strategic Moves & Developments
8.5 Coloplast A/S
8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4 Business Performance
8.6 Acelity L.P. Inc.
8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Operating Business Segments
8.6.4 Business Performance
8.6.5 Key Strategic Moves & Developments
8.7 ConvaTec Inc.
8.7.1 Company Overview
8.7.2 Company Snapshot
8.7.3 Operating Business Segments
8.7.4 Business Performance
8.7.5 Key Strategic Moves & Developments
8.8 Mlnlycke Health Care AB (A subsidiary of INVESTOR AB)
8.8.1 Company Overview
8.8.2 Company Snapshot
8.8.3 Operating Business Segments
8.8.4 Business Performance
8.8.5 Key Strategic Moves & Developments
8.9 Medela AG
8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Operating Business Segments
8.9.4 Business Performance
8.9.5 Key Strategic Moves & Developments
8.10 Cardinal Health, Inc.
8.10.1 Company overview
8.10.2 Operating business segments
8.10.3 Business performance
8.10.4 Key strategic moves & developments
NPWT market growth is driven by various factors such as increase in incidence of chronic diseases such as diabetes mellitus and obesity, and development of cost-effective and portable NPWT devices. Rise in geriatric population and awareness among individuals regarding the NPWT devices have further propelled market growth. However, lack of trained physicians and healthcare services in developing countries hamper the market growth.
For instance, in May 2010, KCI obtained reimbursement approval for the product V.A.C ATS therapy by Japan's Health Insurance Bureau. Moreover, in Europe, countries such as Germany, Sweden, and Austria offer reimbursement policies for in- and outpatient sectors in NPWT devices.
Conventional NPWT devices generated the highest revenue in the global market, owing to the ability of these devices to heal a wide variety of wounds. Single-use NPWT devices is projected to be the fastest growing segment, with CAGR of 5.6%, due to advantages associated with it such as lightweight nature, better reimbursement insurance, and advanced dressing options.
NPWT devices market for chronic wounds is projected to grow with the highest CAGR of 4.0%, due to the increase in incidence of chronic diseases such as diabetes mellitus. Diabetic foot ulcer is the fastest growing segment in chronic wounds, owing to rise in prevalence of diabetes mellitus. In acute wounds, surgical wounds segment is expected to be the grow at the fastest rate on account of their increasing incidence. In end-user segment, hospitals & clinics occupied the major share of the NPWT devices market, as they provide better healing of transplanted skin and fewer chances of infection in case of patients with open wounds. Home care settings was the other dominant application segment, expected to grow at a CAGR of 5.1%.
Key findings of the Negative Pressure Wound Therapy (NPWT) Devices Market:
In the year 2015, conventional NPWT devices was the highest revenue-generating segment and was worth $1,644 million.
In the application segment, chronic wound is projected to be the fastest growing segment, registering a CAGR of 4.0%.
Asia-Pacific is expected to be the fastest growing region in NPWT market by 2022 and is projected to grow at a CAGR of 5.7%.
Germany and France accounted for over two-fifths share of the Europe NPWT devices market in 2015.
In 2015, North America was the highest revenue-generating region, accounting for about two-fifths share of the overall market.
Japan was the highest revenue-generating country in Asia-Pacific in 2015.
In 2015, Germany was the leading country market in Europe and projected to maintain this trend throughout analysis period.
North America accounted for a major share in the world NPWT devices in 2015, and is expected to maintain this trend throughout the forecast period. This is attributed to the rise in the prevalence of chronic wounds, increase in awareness among patients regarding cost-effective NPWT devices, and presence of advanced healthcare facilities. However, Asia-Pacific is expected to be grow at the fastest rate, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of burns and surgical wounds, and high rate of chronic diseases such as diabetes mellitus.
The key players profiled in this report include Acelity, Smith & Nephew, ConvaTec Inc., Mlnlycke Health Care, Coloplast, Cardinal Health, Medela AG, Paul Hartmann AG, Devon Medical, and Talley Group Limited.